Showing results (161-170 of 217) with videos related to
Sort By:
Pageof 22
Molecular Therapy. Methods & Clinical Development|December 10, 2016
Impact of intravenous infusion time on AAV8 vector pharmacokinetics, safety, and liver transduction in cynomolgus macaquesJenny A Greig, Jayme Ml Nordin, Erin Bote, et al.Circulation Research|April 1, 1995
Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heartP A Anderson, A Greig, T M Mark, et al.Journal of Cachexia, Sarcopenia and Muscle|July 3, 2015
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patientsNathan A Stephens, Richard J E Skipworth, Iain J Gallagher, et al.Cancer Gene Therapy|March 14, 2024
Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasisMarcela S Werner, Shweta Aras, Ashleigh R Morgan, et al.BMJ Open|March 17, 2025
Understanding needs and solutions to promote healthy ageing and reduce multimorbidity in Rwanda: a protocol paper for a mixed methods, stepwise research studyAlemayehu Amberbir, Callixte Cyuzuzo, Michael Boah, et al.Frontiers in Physiology|March 4, 2022
Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver DiseaseJonathan I Quinlan, Amritpal Dhaliwal, Felicity Williams, et al.Human Gene Therapy. Clinical Development|January 30, 2019
A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson DiseaseJenny A Greig, Jayme M L Nordin, Melanie K Smith, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 25, 2020
Sarcopenia in chronic liver disease: mechanisms and countermeasuresSophie L Allen, Jonathan I Quinlan, Amritpal Dhaliwal, et al.Human Gene Therapy|June 13, 2018
Optimized Adeno-Associated Viral-Mediated Human Factor VIII Gene Therapy in Cynomolgus MacaquesJenny A Greig, Jayme M L Nordin, John W White, et al.Molecular Therapy. Methods & Clinical Development|August 17, 2018
Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar SyndromeJenny A Greig, Jayme M L Nordin, Christine Draper, et al.Pageof 22